Monoclonal Antibodies to Treat Multiple Myeloma: A Dream Come True

por D’Agostino, Mattia, Innorcia, Salvatore, Boccadoro, Mario, Bringhen, Sara
Publicado 2020

New Strategies for the Treatment of Older Myeloma Patients

por Larocca, Alessandra, Cani, Lorenzo, Bertuglia, Giuseppe, Bruno, Benedetto, Bringhen, Sara
Publicado 2023

Emerging drugs and combinations to treat multiple myeloma

por Larocca, Alessandra, Mina, Roberto, Gay, Francesca, Bringhen, Sara, Boccadoro, Mario
Publicado 2017

In search of the optimal proteosome inhibitor. How, when and for whom?

por Engelhardt, Monika, Bringhen, Sara, Moreau, Philippe, Wäsch, Ralph, Waldschmidt, Johannes
Publicado 2021

The Role of Monoclonal Antibodies in the First-Line Treatment of Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma

por Bonello, Francesca, Grasso, Mariella, D’Agostino, Mattia, Celeghini, Ivana, Castellino, Alessia, Boccadoro, Mario, Bringhen, Sara
Publicado 2020

Melflufen: A Peptide–Drug Conjugate for the Treatment of Multiple Myeloma

por Mateos, María-Victoria, Bladé, Joan, Bringhen, Sara, Ocio, Enrique M, Efebera, Yvonne, Pour, Luděk, Gay, Francesca, Sonneveld, Pieter, Gullbo, Joachim, Richardson, Paul G.
Publicado 2020

Cardiovascular Organ Damage and Blood Pressure Levels Predict Adverse Events in Multiple Myeloma Patients Undergoing Carfilzomib Therapy

por Bruno, Giulia, Bringhen, Sara, Maffei, Ilaria, Iannaccone, Andrea, Crea, Teresa, Ravera, Agnese, Astarita, Anna, Vallelonga, Fabrizio, Salvini, Marco, Gay, Francesca, Veglio, Franco, Milan, Alberto
Publicado 2019

Carfilzomib-Based Regimen and Cardiotoxicity in Multiple Myeloma: Incidence of Cardiovascular Events and Organ Damage in Carfilzomib-Dexamethasone versus Carfilzomib-Lenalidomide-D...

por Astarita, Anna, Mingrone, Giulia, Airale, Lorenzo, Cesareo, Marco, Colomba, Anna, Catarinella, Cinzia, Leone, Dario, Gay, Francesca, Bringhen, Sara, Veglio, Franco, Milan, Alberto, Vallelonga, Fabrizio
Publicado 2023

Melflufen plus dexamethasone in relapsed/refractory multiple myeloma: long‐term survival follow‐up from the Phase II study O‐12‐M1

por Bringhen, Sara, Voorhees, Peter M., Plesner, Torben, Mellqvist, Ulf‐Henrik, Reeves, Brandi, Sonneveld, Pieter, Byrne, Catriona, Nordström, Eva, Harmenberg, Johan, Obermüller, Jakob, Richardson, Paul G.
Publicado 2021

Ultra-Low-Dose Whole-Body Computed Tomography Protocol Optimization for Patients With Plasma Cell Disorders: Diagnostic Accuracy and Effective Dose Analysis From a Reference Center

por Tore, Davide, Rampado, Osvaldo, Guarnaccia, Carla, Mina, Roberto, Oronzio, Maria, Santonocito, Ambra, Serafini, Alessandro, Strazzarino, Giulio Antonino, Gianusso, Laura, Bringhen, Sara, Fonio, Paolo, Depaoli, Alessandro
Publicado 2021

Patients with Very High Risk of Cardiovascular Adverse Events during Carfilzomib Therapy: Prevention and Management of Events in a Single Center Experience

por Mingrone, Giulia, Astarita, Anna, Colomba, Anna, Catarinella, Cinzia, Cesareo, Marco, Airale, Lorenzo, Paladino, Arianna, Leone, Dario, Vallelonga, Fabrizio, Bringhen, Sara, Gay, Francesca, Veglio, Franco, Milan, Alberto
Publicado 2023

Caring for older adults with multiple myeloma during the COVID-19 Pandemic: Perspective from the International Forum for Optimizing Care of Older Adults with Myeloma

por Mian, Hira, Grant, Shakira J., Engelhardt, Monika, Pawlyn, Charlotte, Bringhen, Sara, Zweegman, Sonja, Stege, Claudia A.M., Rosko, Ashley E., von Lilienfeld-Toal, Marie, Wildes, Tanya M.
Publicado 2020

Phase 1b Study of Isatuximab in Combination With Bortezomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed, Transplant-ineligible Multiple Myeloma Patients

por Ocio, Enrique M., Bringhen, Sara, Martinez-Lopez, Joaquin, San-Miguel, Jesus, Oliva, Stefania, Rodriguez-Otero, Paula, Le Roux, Nadia, Dong, Yvonne, Doroumian, Severine, Macé, Sandrine, Mateos, Maria-Victoria
Publicado 2023

Safety of Rapid Daratumumab Infusion: A Retrospective, Multicenter, Real-Life Analysis on 134 Patients With Multiple Myeloma

por Bonello, Francesca, Rocchi, Serena, Barilà, Gregorio, Sandrone, Michela, Talarico, Marco, Zamagni, Elena, Scaldaferri, Matilde, Vedovato, Susanna, Bertiond, Cecilia, Pavan, Laura, Bringhen, Sara, Cattel, Francesco, Zambello, Renato, Cavo, Michele, Mina, Roberto
Publicado 2022

Multiple Myeloma Patients Undergoing Carfilzomib: Development and Validation of a Risk Score for Cardiovascular Adverse Events Prediction

por Astarita, Anna, Mingrone, Giulia, Airale, Lorenzo, Vallelonga, Fabrizio, Covella, Michele, Catarinella, Cinzia, Cesareo, Marco, Bruno, Giulia, Leone, Dario, Giordana, Carlo, Cetani, Giusy, Salvini, Marco, Gay, Francesca, Bringhen, Sara, Rabbia, Franco, Veglio, Franco, Milan, Alberto
Publicado 2021

Effects of Carfilzomib Therapy on Left Ventricular Function in Multiple Myeloma Patients

por Mingrone, Giulia, Astarita, Anna, Airale, Lorenzo, Maffei, Ilaria, Cesareo, Marco, Crea, Teresa, Bruno, Giulia, Leone, Dario, Avenatti, Eleonora, Catarinella, Cinzia, Salvini, Marco, Cetani, Giusy, Gay, Francesca, Bringhen, Sara, Veglio, Franco, Vallelonga, Fabrizio, Milan, Alberto
Publicado 2021

The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review

por Mian, Hira, McCurdy, Arleigh, Giri, Smith, Grant, Shakira, Rochwerg, Bram, Winks, Erica, Rosko, Ashley E., Engelhardt, Monika, Pawlyn, Charlotte, Cook, Gordon, Jackson, Graham, Bringhen, Sara, Facon, Thierry, Larocca, Alessandra, Zweegman, Sonja, Wildes, Tanya M.
Publicado 2023

Isatuximab plus pomalidomide and dexamethasone in elderly patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis

por Schjesvold, Fredrik, Richardson, Paul G., Facon, Thierry, Alegre, Adrián, Spencer, Andrew, Jurczyszyn, Artur, Sunami, Kazutaka, Frenzel, Laurent, Min, Chang-Ki, Guillonneau, Sophie, Lin, Peggy L., Le-Guennec, Solenn, Campana, Frank, van de Velde, Helgi, Bensfia, Samira, Bringhen, Sara
Publicado 2021

Isatuximab plus pomalidomide and dexamethasone in elderly patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis

por Schjesvold, Fredrik, Richardson, Paul G., Facon, Thierry, Alegre, Adrián, Spencer, Andrew, Jurczyszyn, Artur, Sunami, Kazutaka, Frenzel, Laurent, Min, Chang-Ki, Guillonneau, Sophie, Lin, Peggy L., Le-Guennec, Solenn, Campana, Frank, van de Velde, Helgi, Bensfia, Samira, Bringhen, Sara
Publicado 2022

Cardiovascular adverse events in modern myeloma therapy – Incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA)...

por Bringhen, Sara, Milan, Alberto, Ferri, Claudio, Wäsch, Ralph, Gay, Francesca, Larocca, Alessandra, Salvini, Marco, Terpos, Evangelos, Goldschmidt, Hartmut, Cavo, Michele, Petrucci, Maria Teresa, Ludwig, Heinz, Auner, Holger W., Caers, Jo, Gramatzki, Martin, Boccadoro, Mario, Einsele, Hermann, Sonneveld, Pieter, Engelhardt, Monika
Publicado 2018